 |  |  |  |  |
 | ||||
 |  |  |  |
 |
 | ||||
|
||||||||||||||||||||
|
||||||||||||||||||||
(Last revised:
May 5, 2010
)
(Further information: bbch@wiv-isp.be)
Final decisions taken in Belgium on contained use classified in risk class 3
or 4 of GMOs (LMOs) which are likely to be subject to transboundary movements
in accordance with Article 11 of the Protocol, have to be notified to the BCH
within
15 days
of their adoption.
There are currently no such decisions.
According to Article
11
of the Protocol, Belgium shall inform the BCH of any final domestic decision
regarding the deliberate release of GMOs (LMOs) in accordance with part B of
Directive
2001/18/EC (see chapter "regulatory framework") that
may be subject to transboundary movement for direct use as food or feed, or for
processing, within
15 days
of the adoption of that decision.
There are currently no such decisions.
The "Belgian
Biosafety Server" provides a searchable Database with information about
all deliberate releases of GMOs
(LMOs)
into the environment in Belgium for research and development or for any other
purposes
than placing on the market.
A Database
of deliberate releases into the environment of the European Union of GMOs
for any other purposes
than placing on the market is also available on the Web site of the Joint
Research Centre of the European Commission.
Final decisions regarding LMO-FFPs are taken at European Community
level to allow these products to be used throughout the Community (see also the
chapter "regulatory framework").
A list of GMOs (LMOs) that have been authorised for marketing in the European Union for direct use as food or feed, or for processing, is available from the BCH Central Portal.
Final decisions regarding GMOs (LMOs) used as commercial products
are taken at European Community level to allow these products to be used throughout
the Community (see also the chapter "regulatory framework").
A list of GMOs (LMOs) that have been authorised for marketing or submitted for marketing approval in the European Union is available from the European Commission Web Site and from the Web site of the Joint Research Centre of the European Commission.
OECD's Biotech Products Database: Products or regulated articles that have been approved for commercialisation in OECD Member countries.